Post

Biotechnology Industry Immersion
MGT 290-003

Biotechnology has been a disruptive technology in the life sciences industry, especially in biomedical therapeutics and diagnostics. Continued success in the biotechnology industry requires the application of extraordinary leadership and management skills in addition to the scientific innovations.

Fast Facts

  • Curriculum designed by both UC Davis faculty and industry executives to reflect the latest challenges in the industry
  • Gain hands-on experience each week, teaming with MBA and biotech sciences students in problem-solving sessions
  • Five weeks of interactive classes on Fridays in Winter Quarter taught by senior executives from a select group of companies
  • Group assignments in every class, examining potential solutions to management challenges

Speakers & Topics

This course introduces students to the many facets of the biotechnology industry and provides a framework for understanding the complex forces that shape and drive it. 

You’ll learn from top industry executives about:

  • Growth and new developments
  • Drug innovations
  • Entrepreneurship
  • Drug regulations
  • Marketing and commercialization
Friday, January 12, 2018
AM Session Introduction
  Judith A. Kjelstrom, PhD 
Director, UC Davis Biotechnology 
Program Coordinator, Designated Emphasis in Biotechnology Graduate Program 
Lecturer, Microbiology and Molecular & Cell Biology 
PM Session An Introduction to Drug Development 
 

Lonnie Bookbinder, Ph.D., MBA

Founder and CEO

ARIZ Precision Medicine           

Friday, January 19, 2018
AM Session Growing a Small Company: Access to Financial and Human Capital 
 

Glenn Nedwin, Ph.D.

CEO & President

Second Genome, Inc. 

PM Session Issues Encountered when expanding Partnerships and Markets 
 

David Hedin

President and Founder

Expression Systems 

Friday, January 26, 2018
AM Session Challenges of the Government Approval Process 
 

Sharon Barclay Kime, J.D., MPH, BSN

US Head of Regulatory Intelligence

Genentech 

 

Anne Madej
Regulatory Intelligence
Genentech

PM Session 7 Tips for Entrepreneurs 
 

Craig Shimasaki, Ph.D., MBA

President and CEO

Moleculera Labs  

Friday, February 2, 2018
AM Session Marketing and Commercialization of Drugs and Products 
 

Christine Poon (tentative)

Former Vice Chairman

Board of Directors

Johnson & Johnson

 

Jonathan Piazza (tentative)

Managing Director

Healthcare Investment Banking

Barclays Investment Bank

PM Session Supply Chain Issues
 

Charles Calderaro III

Senior Vice President, Global Manufacturing

BioMarin Pharmaceuticals

Friday, February 9, 2018
AM Session Innovations in the Future: Precision Medicine Using Big Data Analytics 
 

Jeff Wesler, Ph.D. 

VP and Lab Director

IBM Research – Almaden 

PM Session Innovations in the Future: Stem Cells and Targeted Therapies 
 

Christopher Murriel, Ph.D.

Associate Director

Department of Cancer Biology

OncoMed Pharmaceuticals, Inc.